HIV Infections Clinical Trial
Official title:
An Open Label, Non-randomized Treatment Protocol of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Protease Inhibitor-experienced Patients With HIV-1 Infection (the Tipranavir Expanded Access Program)
| Verified date | October 2013 |
| Source | Boehringer Ingelheim |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Food and Drug Administration |
| Study type | Expanded Access |
This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.
— Not specified —
N/A
| Country | Name | City | State |
|---|---|---|---|
| United States | 1182.70.065 | Anaheim | California |
| United States | 1182.70.011 | Annadale | Virginia |
| United States | 1182.70.127 Health Services Center, Inc. | Anniston | Alabama |
| United States | 1182.70.061 | Asheville | North Carolina |
| United States | 1182.70.002 | Atlanta | Georgia |
| United States | 1182.70.046 | Atlanta | Georgia |
| United States | 1182.70.069 | Atlanta | Georgia |
| United States | 1182.70.018 | Austin | Texas |
| United States | 1182.70.246 | Baldwin Park | California |
| United States | 1182.70.025 Chase Brexton Health Services, Inc | Baltimore | Maryland |
| United States | 1182.70.004 | Berkley | Michigan |
| United States | 1182.70.082 | Boston | Massachusetts |
| United States | 1182.70.090 | Boston | Massachusetts |
| United States | 1182.70.024 | Briarcliff Manor | New York |
| United States | 1182.70.105 | Bronk | New York |
| United States | 1182.70.250 Montefiore Medical Center | Bronx | New York |
| United States | 1182.70.100 | Chapel Hill | North Carolina |
| United States | 1182.70.126 | Charleston | South Carolina |
| United States | 1182.70.271 | Charleston | South Carolina |
| United States | 1182.70.136 Mecklenburg Medical Group, P.A. | Charlotte | North Carolina |
| United States | 1182.70.019 | Chicago | Illinois |
| United States | 1182.70.029 Dr. David Moore | Chicago | Illinois |
| United States | 1182.70.194 | Chicago | Illinois |
| United States | 1182.70.241 University of CIncinnati Medical Center | Cincinnati | Ohio |
| United States | 1182.70.088 | Columbia | South Carolina |
| United States | 1182.70.037 | Dactur | Georgia |
| United States | 1182.70.038 | Dallas | Texas |
| United States | 1182.70.041 | Dallas | Texas |
| United States | 1182.70.055 | Dallas | Texas |
| United States | 1182.70.070 | Dallas | Texas |
| United States | 1182.70.218 Denver Infectious Disease Consultants | Denver | Colorado |
| United States | 1182.70.281 | Denver | Colorado |
| United States | 1182.70.084 | Detroit | Michigan |
| United States | 1182.70.103 | Durham | North Carolina |
| United States | 1182.70.060 | El Paso | Texas |
| United States | 1182.70.003 | Fort Lauderdale | Florida |
| United States | 1182.70.013 | Fort Lauderdale | Florida |
| United States | 1182.70.049 | Fort Lauderdale | Florida |
| United States | 1182.70.096 | Fort Lauderdale | Florida |
| United States | 1182.70.045 | Fort Myers | Florida |
| United States | 1182.70.043 | Fountain Valley | California |
| United States | 1182.70.092 | Fresno | California |
| United States | 1182.70.057 | Glendale | California |
| United States | 1182.70.288 Hackensack University Medical Center | Hackensack | New Jersey |
| United States | 1182.70.064 | Harbor City | California |
| United States | 1182.70.026 | Hollywood | Florida |
| United States | 1182.70.052 | Houston | Texas |
| United States | 1182.70.054 | Houston | Texas |
| United States | 1182.70.285 | Houston | Texas |
| United States | 1182.70.167 | Indianapolis | Indiana |
| United States | 1182.70.192 | Iowa City | Iowa |
| United States | 1182.70.058 | Jesup | Georgia |
| United States | 1182.70.010 | Joliet | Illinois |
| United States | 1182.70.039 | Kingston | New York |
| United States | 1182.70.021 | Las Vegas | Nevada |
| United States | 1182.70.093 | Lincoln | Nebraska |
| United States | 1182.70.016 Health for Life Clinic | Little Rock | Arkansas |
| United States | 1182.70.079 | Long Beach | California |
| United States | 1182.70.015 | Los Angeles | California |
| United States | 1182.70.053 | Los Angeles | California |
| United States | 1182.70.066 | Los Angeles | California |
| United States | 1182.70.071 | Los Angeles | California |
| United States | 1182.70.137 | Los Angeles | California |
| United States | 1182.70.198 | Los Angeles | California |
| United States | 1182.70.174 | Macon | Georgia |
| United States | 1182.70.023 | Miami | Florida |
| United States | 1182.70.165 Comprehensive Care Center | Nashville | Tennessee |
| United States | 1182.70.074 | New Haven | Connecticut |
| United States | 1182.70.099 | New Orleans | Louisiana |
| United States | 1182.70.028 | New York | New York |
| United States | 1182.70.031 | New York | New York |
| United States | 1182.70.036 | New York | New York |
| United States | 1182.70.050 | New York | New York |
| United States | 1182.70.062 | New York | New York |
| United States | 1182.70.104 | New York | New York |
| United States | 1182.70.008 | Newport Beach | California |
| United States | 1182.70.040 | North Palm Beach | Florida |
| United States | 1182.70.073 | Norwich | Connecticut |
| United States | 1182.70.081 | Oakland | California |
| United States | 1182.70.095 | Oakland | California |
| United States | 1182.70.007 | Orlando | Florida |
| United States | 1182.70.067 | Panorama City | California |
| United States | 1182.70.051 | Philadelphia | Pennsylvania |
| United States | 1182.70.080 | Philadelphia | Pennsylvania |
| United States | 1182.70.006 Spectrum Medical Group | Phoenix | Arizona |
| United States | 1182.70.117 | Plantation | Florida |
| United States | 1182.70.017 | Pompano Beach | Florida |
| United States | 1182.70.044 | Portland | Oregon |
| United States | 1182.70.059 Fanno Creek Clinic | Portland | Oregon |
| United States | 1182.70.077 Kaiser Permanente-IDC | Portland | Oregon |
| United States | 1182.70.072 | Providence | Rhode Island |
| United States | 1182.70.217 | Richmond | Virginia |
| United States | 1182.70.086 Boehringer Ingelheim Investigational Site | Rochester | New York |
| United States | 1182.70.128 Olmos Park Medical Associates | San Antonio | Texas |
| United States | 1182.70.033 | San Diego | California |
| United States | 1182.70.014 | San Francisco | California |
| United States | 1182.70.020 | San Francisco | California |
| United States | 1182.70.048 | San Francisco | California |
| United States | 1182.70.085 | San Francisco | California |
| United States | 1182.70.214 | San Francisco | California |
| United States | 1182.70.022 | San Rafael | California |
| United States | 1182.70.097 | Seattle | Washington |
| United States | 1182.70.76 | Seattle | Washington |
| United States | 1182.70.075 | Sommers Point | New Jersey |
| United States | 1182.70.083 | Spokane | Washington |
| United States | 1182.70.035 | St. Louis | Missouri |
| United States | 1182.70.242 | St. Louis | Missouri |
| United States | 1182.70.222 | Stanford | California |
| United States | 1182.70.005 | Tarzana | California |
| United States | 1182.70.030 | Tarzana | California |
| United States | 1182.70.032 | Washington | District of Columbia |
| United States | 1182.70.042 | Washington | District of Columbia |
| United States | 1182.70.289 Dupont Circle Physicians Group | Washington | District of Columbia |
| United States | 1182.70.047 | West Palm Beach | Florida |
| United States | 1182.70.068 | Woodland Hills | California |
| Lead Sponsor | Collaborator |
|---|---|
| Boehringer Ingelheim |
United States,
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05454514 -
Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS
|
N/A | |
| Completed |
NCT03760458 -
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
|
Phase 1/Phase 2 | |
| Completed |
NCT03067285 -
A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study
|
Phase 4 | |
| Completed |
NCT03141918 -
Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS
|
N/A | |
| Recruiting |
NCT04579146 -
Coronary Artery Disease (CAD) in Patients HIV-infected
|
||
| Completed |
NCT06212531 -
Papuan Indigenous Model of Male Circumcision
|
N/A | |
| Active, not recruiting |
NCT03256422 -
Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients
|
Phase 3 | |
| Completed |
NCT03256435 -
Retention in PrEP Care for African American MSM in Mississippi
|
N/A | |
| Completed |
NCT00517803 -
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
|
N/A | |
| Active, not recruiting |
NCT03572335 -
Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
|
||
| Completed |
NCT04165200 -
Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV
|
N/A | |
| Recruiting |
NCT03854630 -
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
|
Phase 4 | |
| Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
| Completed |
NCT02234882 -
Study on Pharmacokinetics
|
Phase 1 | |
| Completed |
NCT01618305 -
Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
|
Phase 4 | |
| Recruiting |
NCT05043129 -
Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
|
||
| Not yet recruiting |
NCT05536466 -
The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine
|
N/A | |
| Recruiting |
NCT04985760 -
Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy
|
Phase 1 | |
| Completed |
NCT05916989 -
Stimulant Use and Methylation in HIV
|
||
| Terminated |
NCT02116660 -
Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)
|
Phase 2 |